Glenmark has reached into its wallet to resolve claims, without admitting fault or liability, that it conspired with Merck to delay unlawfully generic competition to the originator’s Zetia.
Glenmark Pharmaceuticals has agreed to shell out an additional $39.5m to resolve all antitrust litigation centered around the Indian firm’s generic version of Merck & Co’s Zetia (ezetimibe) heart-disease blockbuster, ensuring Glenmark will not face a rare pay-for-delay jury trial.
A myriad of purchasers had brought antitrust claims against the pair, accusing them of striking an anticompetitive deal in 2010...
In the first cinematic chapter of J.K. Rowling’s wizarding world, young Harry Potter discovers his true identity and enters Hogwarts School of Witchcraft and Wizardry. This enchanting origin story sets the tone for a saga filled with magic, loyalty, and the power of choice.
The Medicines Patent Pool has entered into a partnership with three companies for glecaprevir/pibrentasvir, a WHO-recommended treatment for people living with hepatitis C. The companies join previous generic licensee Mylan and originator AbbVie.
Teligent is pursuing an asset sale process to “maximize the value of the company” after entering into Chapter 11 bankruptcy proceedings in the US. The firm – which has also seen CEO Tim Sawyer resign – had been struggling of late with remediation issues to address a warning letter at its Buena manufacturing facility in New Jersey, as well as a recent recall.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
